Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety

Last updated: November 20, 2025
Sponsor: Tianjin Medical University General Hospital
Overall Status: Completed

Phase

N/A

Condition

Narcolepsy

Sleep Disorders

Insomnia

Treatment

Remimazolam

normal Saline

Esketamine

Clinical Study ID

NCT06284668
GWang027
  • Ages 18-45
  • Female

Study Summary

To explore and compare the effects of esketamine and remimazolam on postoperative sleep disturbance in patients undergoing oocyte retrieval

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age 18-45 years old;

  2. American society of Aneshesiologists(ASA)physical status classification system isgrade I-III;

  3. Elective surgery is proposed

  4. BMI of 19-30 kg/m2;

  5. Patients who agreed to enroll in this study voluntarily

Exclusion

Exclusion Criteria:

  1. Those who are known to be allergic to the drug ingredients in this study and theirallergic constitution;

  2. Allergic history of general anesthesia drugs, opioid drugs, non-steroidal drugs;

  3. History of neurological diseases; History of chronic pain; Drug and alcoholaddiction; A long history of opioid use; Opiates were given 48 hours before surgery

  4. Coronary heart disease, bronchial asthma, severe hypertension, severe blood systemdysfunction, liver and kidney function, electrolyte abnormalities;

  5. Respiratory insufficiency, respiratory failure;

  6. BMI<18 kg/m2 or BMI>30kg/m2;

  7. Poor compliance, unable to complete the experiment according to the study plan;Participants who have participated in clinical trials of other drugs within the last 4 weeks;

  8. Preoperative Pittsburgh Sleep Quality Index (PSQI) higher than 7

  9. Any circumstances deemed unsuitable for inclusion by the researcher for any reason.

Study Design

Total Participants: 315
Treatment Group(s): 3
Primary Treatment: Remimazolam
Phase:
Study Start date:
March 04, 2024
Estimated Completion Date:
May 20, 2025

Study Description

Postoperative sleep disturbance (PSD) occur in the form of sleep deprivation, circadian rhythm disturbance, and structural abnormalities, and have a high incidence in patients undergoing surgery. Postoperative sleep disorders can lead to postoperative delirium and cognitive dysfunction, aggravate postoperative acute pain, and delay postoperative recovery.

Benzodiazepines have a certain sedative hypnotic anti-anxiety effect, and remimazolam as a new benzodiazepine, its sedative hypnotic anti-anxiety effect is worthy of further exploration. Esketamine is an N-methyl-D-aspartate(NMDA) receptor antagonist with analgesic and sedative effects, and is widely used in clinical treatment of refractory depression. For patients undergoing surgery, in addition to sedation and analgesia, whether the intraoperative use of esketamine has positive effects on postoperative sleep disturbance is worth exploring.

Connect with a study center

  • Tianjin Medical University General Hospital

    Tianjin, 300052
    China

    Site Not Available

  • Tianjin Medical University General Hospital

    Tianjin 1792947, 300052
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.